Evaluating Use of Continuous Glucose Monitors in a Short-term 2x2-Crossover Study

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

April 29, 2018

Study Completion Date

June 29, 2018

Conditions
Diabetes Type 2Diabetes Mellitus
Interventions
OTHER

WB-011

WB-011 medical food product.

OTHER

Placebo

Placebo Capsules identical to those containing WB-011.

DEVICE

Continuous Glucose Monitor

Abbott Freestyle Libre(™) Glucose Sensors were used throughout the study.

Trial Locations (1)

94107

Pendulum Therapeutics Inc, San Francisco

Sponsors
All Listed Sponsors
lead

Pendulum Therapeutics

INDUSTRY